skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
Trimethylamine-N-oxide in the Healthy and Diseased Heart
Digital Resources/Online E-Resources
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Trimethylamine-N-oxide in the Healthy and Diseased Heart
Author:
Naghipour, Saba
;
Du Toit, Eugene
;
Headrick, John P
;
Peart, Jason N
;
Fisher, Joshua
Subjects:
cardiovascular disease
;
diabetes
;
mitochondria
;
trimethylamine-N-oxide (TMAO)
Description:
Cardiovascular disease (CVD) remains the greatest cause of death globally, despite ongoing efforts to prevent disease and optimise clinical therapies. The development of CVD is largely dependent on lifestyle risk factors prevalent in modern societies, including poor diet and exercise habits, smoking status, low socioeconomic status, and psychosocial stresses. A lifestyle of chronic unhealthy eating habits, together with these factors, drives common metabolic disorders such as type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS), both strongly contributing to the risk of CVD. Over recent decades, a growing body of literature identifies and supports a key role for the gut microbiome in the aetiology of our most common chronic diseases, including CVD. Indeed, dietary factors not only governs overall energy balance, but influences the gut microbiome. In particular, the gut microbial metabolite trimethylamine-N-oxide (TMAO) has been identified as a potential player in the linkages between diet, the gut microbiome, and CVD development and outcomes. Elevations in circulating TMAO have been observed in chronic (often comorbid) disorders such as obesity, T2DM, heart failure and chronic kidney disease, as well as in advanced age. Additionally, studies using in vitro and in vivo models indicate that TMAO may well promote CVD, enhancing atherosclerotic disease via stimulatory effects on inflammation and oxidative stress. Despite considerable ongoing investigations, some fundamental questions remain unaddressed. Critically, the TMAO concentrations commonly used to induce and study such pathological outcomes are generally many-fold higher than observed in human disorders, and animal models of disease. In addition, it is not clear whether TMAO can induce pathology in otherwise healthy people, in the absence of co-morbidities. Findings are conflicting in this regard, thus it remains to be established whether TMAO actively drives disease or represents a potentially useful biomarker secondary to evolving cardiometabolic disease. In terms of cardiovascular influences, most in vitro and in vivo studies focus on vascular and inflammatory effects, with much less information available regarding both myocardial and also mitochondrial effects of TMAO. The latter mitochondrial dysfunction is broadly implicated in common cardiometabolic diseases. Given these unknowns, and gaps in the literature regarding TMAO in CVD, this doctoral project sought to establish whether extracellular concentrations of TMAO observed in mild and severe cardiovascular or related metabolic diseases are sufficient to independently impact the heart, its vessels, and myocardial mitochondria. Questions addressed include whether cardiovascular effects are evident with acute elevations in TMAO or require chronic changes; do such effects emerge in otherwise healthy hearts or are they more evident in extant disease; and, what are the relationships between TMAO concentrations, cardiometabolic risk factors, diet, and gut microbiome profile. […] Thesis (PhD Doctorate) Doctor of Philosophy (PhD) School of Pharmacy & Med Sci Griffith Health Full Text Source: TROVE
Creation Date:
2023
Language:
English
Source:
Trove Australian Thesis (Full Text Open Access)
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript